In our case series, case 3 was diagnosed as having guanidinoacetate methyltransferase (GAMT) deficiency, a rare but treatable subtype of cerebral creatine deficiency syndromes (CCDS). The gene discussed is GAMT; the disease is cerebral creatine deficiency syndrome.